Home LiteratureArticle Details
PMID: 10525558 Published · ppublish English Clinical Trial Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.

Thorax ·Vol. 54 ·No. 11 ·1999-11-00 ·Pages 995-1003

Rutten-van Mölken M, Roos B, Van Noord JA

Abstract

The Chronic Respiratory Questionnaire (CRQ) and the St George's Respiratory Questionnaire (SGRQ) are the two most widely used quality of life questionnaires in chronic obstructive pulmonary disease (COPD). A study was undertaken to compare directly the self-administered version of the CRQ and the SGRQ with respect to feasibility, internal consistency, validity, and sensitivity to changes resulting from bronchodilator therapy. One hundred and forty four patients with moderate or severe COPD were randomly assigned to receive three months of treatment with either salmeterol, salmeterol + ipratropium bromide, or placebo. Quality of life was measured at baseline and after 12 weeks of treatment. The proportions of missing values per patient were low for both questionnaires (0.54% for the CRQ and 2% for the SGRQ). The internal consistency was good for both questionnaires (Cronbach's alpha coefficients >/= 0.84 for the CRQ and >/= 0.76 for the SGRQ). Factor analysis confirmed the original domain structure of the CRQ but not of the SGRQ. Correlations with forced expiratory volume in one second (FEV(1)) % predicted and peak expiratory flow rate (PEFR) were low for both questionnaires but better for the SGRQ than for the CRQ. The ability to discriminate between subjects with different levels of FEV(1) was somewhat better for the SGRQ. The correlations with symptom scores were comparable for both questionnaires. Cross sectionally, the scores of the two questionnaires were moderately to highly correlated (coefficients ranged from 0.35 to 0.72). Longitudinally, these correlations were lower (coefficients ranged from 0.17 to 0.54) but were still significant. The CRQ total and emotions score and the SGRQ symptoms score were the most responsive to change. The SGRQ symptoms domain was the only domain where the improvement in patients receiving combination treatment crossed the threshold for clinical relevance. Since this analysis of reliability, validity, and responsiveness to change did not clearly favour one instrument above the other, the choice between the CRQ and the SGRQ can be based on other considerations such as the required sample size or the availability of reference values.

MeSH Terms
Adult Aged Albuterol/analogs & derivatives,therapeutic use Bronchodilator Agents/therapeutic use Double-Blind Method Feasibility Studies Female Humans Ipratropium/therapeutic use Lung Diseases, Obstructive/drug therapy Male Middle Aged Quality of Life Reproducibility of Results Salmeterol Xinafoate Sensitivity and Specificity Surveys and Questionnaires/standards
Chemicals
Bronchodilator Agents Salmeterol Xinafoate Ipratropium Albuterol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rutten-van Mölken M
Institute for Medical Technology Assessment, Erasmus University Rotterdam, 3000 DR Rotterdam, The Netherlands.
Roos B
Van Noord J A
References (25)
25 references, click to expand
  1. Quality of life changes in COPD patients treated with salmeterol.
    Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9 PMID: 9105068
  2. Clinical impact versus factor analysis for quality of life questionnaire construction.
    J Clin Epidemiol. 1997 Mar;50(3):233-8 PMID: 9120521
  3. Long-term outcome of pulmonary rehabilitation in patients with COPD.
    Chest. 1997 Aug;112(2):363-9 PMID: 9266870
  4. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.
    Thorax. 1997 Oct;52(10):879-87 PMID: 9404375
  5. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90 PMID: 9517591
  6. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis.
    Eur Respir J. 1998 Dec;12(6):1284-9 PMID: 9877478
  7. Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy.
    Eur Respir J. 1997 Jul;10(7):1572-5 PMID: 9230249
  8. A measure of quality of life for clinical trials in chronic lung disease.
    Thorax. 1987 Oct;42(10):773-8 PMID: 3321537
  9. Should study subjects see their previous responses: data from a randomized control trial.
    J Clin Epidemiol. 1989;42(9):913-20 PMID: 2778469
  10. Measurement of health status. Ascertaining the minimal clinically important difference.
    Control Clin Trials. 1989 Dec;10(4):407-15 PMID: 2691207
  11. Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
    Respir Med. 1989 Jul;83(4):293-7 PMID: 2692093
  12. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries.
    Eur Respir J. 1991 Feb;4(2):167-71 PMID: 2044732
  13. The St George's Respiratory Questionnaire.
    Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7 PMID: 1759018
  14. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
    Am Rev Respir Dis. 1992 Jun;145(6):1321-7 PMID: 1595997
  15. Reliability and validity of the chronic respiratory questionnaire (CRQ).
    Thorax. 1994 May;49(5):465-7 PMID: 8016767
  16. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Thorax. 1994 May;49(5):479-84 PMID: 8016770
  17. Randomised controlled trial of respiratory rehabilitation.
    Lancet. 1994 Nov 19;344(8934):1394-7 PMID: 7968075
  18. [The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease].
    Arch Bronconeumol. 1995 May;31(5):202-10 PMID: 7788081
  19. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease.
    Thorax. 1995 Aug;50(8):824-8 PMID: 7570431
  20. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.
    Eur Respir J. 1995 Aug;8(8):1398-420 PMID: 7489808
  21. [Validation of the St George's questionnaire for measuring the quality of life in patients with chronic obstructive pulmonary disease].
    Rev Mal Respir. 1996;13(1):43-6 PMID: 8650415
  22. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
    Eur Respir J. 1996 Jun;9(6):1160-6 PMID: 8804932
  23. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.
    Lancet. 1996 Oct 26;348(9035):1115-9 PMID: 8888163
  24. Assessing the minimal important difference in symptoms: a comparison of two techniques.
    J Clin Epidemiol. 1996 Nov;49(11):1215-9 PMID: 8892486
  25. The minimal important difference: who's to say what is important?
    J Clin Epidemiol. 1996 Nov;49(11):1221-2 PMID: 8892487
Article Info
Journal
Thorax
Abbr.
Thorax
ISSN
0040-6376
Published
1999-11-00
Pages
995-1003
Language
English
Region
England
NLM ID
0417353
PMCID
PMC1745382
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]